ACADIA Pharmaceuticals, Inc. (ACAD)
26.78
-0.13
(-0.48%)
USD |
NASDAQ |
Jan 09, 16:00
26.79
+0.01
(+0.04%)
After-Hours: 20:00
ACADIA Pharmaceuticals Research and Development Expense (Quarterly): 87.83M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 23.42M |
| ANI Pharmaceuticals, Inc. | 12.30M |
| Catalyst Pharmaceuticals, Inc. | 2.657M |
| Regeneron Pharmaceuticals, Inc. | 1.338B |
| Vanda Pharmaceuticals, Inc. | 22.56M |